Back to top

XERS forms Stochastic Reached Oversold on September 15

Xeris Pharmaceuticals, Inc. (XERS) — Nightly Technical Analysis · Sep 15, 2025, 17:36 ET
XERS posted a 1.74% loss on Monday, September 15th, accompanied by 0.6× normal trading volume. consolidation patterns formed: Bollinger Band Squeeze, suggesting a potential continuation after price stabilization. Key support levels exist at 7.29, 7.22 & 7.11, with resistance at 7.48, 7.59 & 7.66. Additionally, Slow Stochastic points to oversold territory, hinting at a potential consolidation.

Current SwingTradeBot Technical Rating of XERS: C

More charts, more signals, more insights—only on SwingTradeBot.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Xeris Biopharma Holdings, Inc. (XERS)